Knowledge hub

Knowledge hub
News

Ardigen has received funding to accelerate its AI-driven TCR discovery platform for novel cell therapies

PRISM – a writing assistant for the language of proteins
AI aided design of epitope-based vaccine for the induction of cellular immune responses against SARS-CoV-2
Leveraging biomarkers to bring the right treatment to the right patient
Ardigen enters into research collaboration with CVC to apply Artificial Intelligence for identification of T-cell targets – press release
Fishing out hypotheses from a sea of data: how Ardigen’s AIKE helps scientists ask better questions
AACR poster -2
Microbial signatures of response to anti-PD1 therapy in metastatic melanoma patients
AACR poster – 1
Accounting for immune escape mechanisms in personalized and shared neoantigen cancer vaccine design
Understanding microbial proteins with deep learning – part 2
Blog

Understanding microbial proteins with deep learning – part 1

Selvita and Ardigen will receive funding for the development of an AI-based high-content screening platform
We are ready to support your efforts in the fight against COVID-19
Safety considerations for COVID-19 vaccines and antibody-based therapies
The microbiome as a potential weapon against novel coronavirus SARS-CoV-2
Ardigen at AI Powered Drug Discovery and Manufacturing Conference
A new publication about molecule property prediction: Molecule Attention Transformer
A new report about the use of medical data to develop AI in Poland
Ardigen at PMWC 2020
  • Services
  • Technology
Social Media
United States

611 Gateway Boulevard
South San Francisco, CA 94080
USA
tel.+1 628 200 09 14

One Broadway, 14th Floor
Cambridge, MA 02142
USA
tel.+1 628 200 09 14

European Union

Sternbacha 1
30-394 Kraków
Poland
tel.+48 12 340 94 94